A post-doctoral fellow position is available in the laboratory of Dr. Xiaolei Xu, Professor of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine. The successful applicant will join a team that is leveraging powerful zebrafish genetics to model human cardiovascular diseases, to decipher underlying mechanisms, and to develop new therapies. Below please find two representative manuscripts from the lab on doxorubicin-induced cardiotoxicity. Applications are invited from candidates who have a strong background in molecular biology, genetics and/or cardiovascular diseases. Previous experience in animal models of human diseases and/or bioinformatics are favored, but not required. Qualified candidates must be self-motivated and have a strong commitment to basic research. Further enquires (enclosing a CV) regarding the scope and detail of the project should be addressed to: email@example.com or visit https://www.mayo.edu/research/labs/zebrafish-genetics
- Ma X, Zhu P, Ding Y, Zhang H, Qiu Q, Dvornikov AV, Kim M, Wang Y, Lowerison M, Herrmann J, Ekker S, Hsiai TK, Lin X and Xu X. (2020) Retinoid X receptor alpha is a spatiotemporally-specific therapeutic target for doxorubicin-induced cardiomyopathy in adult zebrafish. Science Advances 6(5), eaay2939, PMID: 32064346.
- Wang Y, Lu X, Wang X, Qiu Q, Zhu P, Ma L, Ma X, Herrmann J, Lin X, Wang W, Xu X. (2021) atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity. Circ Res. Aug 13. PMID: 34384247.
Mayo Clinic College of Medicine is a not-for-profit organization that integrates research with clinical practices and education in multi-campus environment. Mayo offers an attractive benefit package. Salary will be determined by the successful candidate's experience.
Applications, including curriculum vitae and bibliography, summary of past accomplishments, and the names of three references, should be sent to:
Xiaolei Xu, PhD.
200 First Street SW
Rochester, MN USA 55905
Phone number: 507-284-0685